These findings support the hypothesis that tau phosphorylation may initially be a protective or compensatory mechanism in the pathogenesis of AD to suppress apoptosis and imbalance in neural transmission and Ca2+-signaling that follow hypometabolism, whose causes are still unclear. This evidence concerns the gene MAPT and Alzheimer disease.